Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl E Allen

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
Annals of Epidemiology|May 5, 2018
The role of parental and perinatal characteristics on Langerhans cell histiocytosis: characterizing increased risk among HispanicsErin C Peckham-Gregory, Kenneth L McClain, Carl E Allen, et al.
Cellular Signalling|August 25, 2010
ZAS3 accentuates transforming growth factor β signaling in epithelial cellsAdam J Yakovich, Bo Jiang, Carl E Allen, et al.
Blood|October 1, 2016
Hydroxyurea: a new old therapy for Langerhans cell histiocytosisDaniel J Zinn, Amanda B Grimes, Howard Lin, et al.
Pediatric Blood & Cancer|January 13, 2009
Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosisPatrick A Thompson, Carl E Allen, Terzah Horton, et al.
Plos One|August 24, 2012
Optimal therapy for adults with Langerhans cell histiocytosis bone lesionsMaria A Cantu, Philip J Lupo, Mrinalini Bilgi, et al.
Pediatrics|December 5, 2006
Pediatric residency duty hours before and after limitationsWilliam L Cull, Holly J Mulvey, Ethan A Jewett, et al.
Pediatric Hematology and Oncology|January 11, 2013
Resection of mediastinal castleman's disease: a case reportBethany J Slater, Andrew B Nordin, Carl E Allen, et al.
Pediatric Hematology and Oncology|February 10, 2022
Prevalence of the <i>BRAF</i> <sup>V600E</sup> mutation in Greek adults with Langerhans cell histiocytosisDimitra Stathi, Maria P Yavropoulou, Carl E Allen, et al.
Gene Expression|February 9, 2008
Disruption of ZAS3 in mice alters NF-kappaB and AP-1 DNA binding and T-cell developmentCarl E Allen, John Richards, Natarajan Muthusamy, et al.
Practical Radiation Oncology|May 7, 2018
Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chestGary D Lewis, Jennifer E Agrusa, Bin S Teh, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Annals of Epidemiology|May 5, 2018
The role of parental and perinatal characteristics on Langerhans cell histiocytosis: characterizing increased risk among HispanicsErin C Peckham-Gregory, Kenneth L McClain, Carl E Allen, et al.
Cellular Signalling|August 25, 2010
ZAS3 accentuates transforming growth factor β signaling in epithelial cellsAdam J Yakovich, Bo Jiang, Carl E Allen, et al.
Blood|October 1, 2016
Hydroxyurea: a new old therapy for Langerhans cell histiocytosisDaniel J Zinn, Amanda B Grimes, Howard Lin, et al.
Pediatric Blood & Cancer|January 13, 2009
Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosisPatrick A Thompson, Carl E Allen, Terzah Horton, et al.
Plos One|August 24, 2012
Optimal therapy for adults with Langerhans cell histiocytosis bone lesionsMaria A Cantu, Philip J Lupo, Mrinalini Bilgi, et al.
Pediatrics|December 5, 2006
Pediatric residency duty hours before and after limitationsWilliam L Cull, Holly J Mulvey, Ethan A Jewett, et al.
Pediatric Hematology and Oncology|January 11, 2013
Resection of mediastinal castleman's disease: a case reportBethany J Slater, Andrew B Nordin, Carl E Allen, et al.
Pediatric Hematology and Oncology|February 10, 2022
Prevalence of the <i>BRAF</i> <sup>V600E</sup> mutation in Greek adults with Langerhans cell histiocytosisDimitra Stathi, Maria P Yavropoulou, Carl E Allen, et al.
Gene Expression|February 9, 2008
Disruption of ZAS3 in mice alters NF-kappaB and AP-1 DNA binding and T-cell developmentCarl E Allen, John Richards, Natarajan Muthusamy, et al.
Practical Radiation Oncology|May 7, 2018
Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chestGary D Lewis, Jennifer E Agrusa, Bin S Teh, et al.
Pageof 14